FDA Adverse Event Injury Summary report: N

ACRYSOF IQ TORIC

MDR report key: 1716500 · Received June 9, 2010

Report

Report Number
1119421-2010-00667
Event Type
Injury
Date Received
June 9, 2010
Date of Event
January 1, 2010
Report Date
May 10, 2010
Manufacturer
ALCON RESEARCH, LTD./HUNTINGTON
Product Code
MJP
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR ANALYSIS; THE DEVICE REMAINS IMPLANTED. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT #. ADDITIONAL INFO WAS REQUESTED ON 05/18/2010, 05/20/2010, AND 05/26/2010 BY PHONE, FAX, AND MAIL. A COMPLETED QUESTIONAIRE HAS NOT BEEN RECEIVED. MEDICAL RECORDS WERE RECEIVED ON 05/20/2010. (B) (4).(B) (4).(B) (4).

Description of Event or Problem · 1

ADVERSE EVENT(S): "UNEXPECTED POSTOPERATIVE REFRACTION" (POSTOPERATIVE REFRACTION, UNEXPECTED); "IRITIS" (IRITIS); "BLURRY VISION" (BLURRED VISION). PRODUCT PROBLEM(S): "NONE REPORTED" (NO INFO [IOL (INTRAOCULAR LENS) IMPLANT]). A SURGEON REPORTED A PT WITH AN UNEXPECTED POSTOPERATIVE REFRACTION FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT SURGERY. MEDICAL RECORDS WERE REQUESTED AND RECEIVED. ACCORDING TO THE MEDICAL RECORDS, THE PT HAD A HISTORY OF HYPERTENSION AND ASTIGMATISM (PRE-EXISTING). FOLLOWING THE IOL IMPLANT PROCEDURE, THE PT REPORTED HER DISTANCE VISION WAS NOT CLEAR. THE SURGEON NOTED RESIDUAL ASTIGMATISM. ACCORDING TO THE MEDICAL RECORDS, THE PT WAS DIAGNOSED WITH IRITIS AND TREATED WITH MEDICATIONS. FOLLOWING TREATMENT, THE PT STATED SHE HAD BLURRY VISION AT NEAR AND DISTANCE. THE PT REPORTED HER EYE FELT BETTER FOLLOWING TREATMENT, BUT HER VISION REMAINED BLURRY. ADDITIONAL INFO HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACRYSOF IQ TORIC INTRAOCULAR LENS MJP ALCON RESEARCH, LTD./HUNTINGTON SN6AT4 10974377

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention POTASSIUM| COD LIVER OIL| TAMOFLOXIN| PROVASTATIN| ATENOLOL| SUBTENONS KENALOG INJECTION| VIT D| MAGNESIUM